AHA Coding Clinic® for HCPCS - 2011 Issue 1; FOR your INFORMATION
New HCPCS Codes for Reporting Drugs and Biologicals
Several new HCPCS codes have been created for the reporting of drugs and biologicals in the hospital outpatient setting. These codes have been effective since January 1, 2011. A listing of the new HCPCS codes for certain drugs, biologicals, and radiopharmaceuticals for calendar year (CY) are as follows: CY 2011 HCPCS Code CY 2011 HCPCS Long Descriptor C9274 Crotalidae Polyvalent Immune Fab (Ovine), 1 vial C9275 Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose C9276 Injection, cabazitaxel, 1 mg C9277 Injection, alglucosidase alfa (Lumizyme), 1 mg C9278 Injection, incobutulinumtoxin A, 1 unit C9279 Injection, ibuprofen, 100 mg J0638 Injection...
Subscribe or sign in to view the full article.
Article Overview
This article is a short HCPCS update focused on new reporting codes introduced for hospital outpatient claims. It is useful for hospital outpatient coders, billing staff, and compliance teams who need to track annual code additions for drugs, biologicals, and radiopharmaceutical-related items. The content provides a code listing and a brief context for the effective period.
Why This Topic Matters
Annual HCPCS updates affect charge capture, claim submission, and code maintenance workflows in hospital outpatient settings. Staying current helps organizations align billing processes with the latest reporting requirements.
What You Will Learn
- Which types of HCPCS reporting updates are included in the article.
- How the article frames the use of new codes in the hospital outpatient setting.
- Which calendar year the listed code additions apply to.
- The general categories of products covered by the update.
Who Should Read This
- Hospital outpatient coders
- Outpatient billing staff
- Revenue cycle teams
- Compliance and HIM professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com